The integration of biomarkers and patient-reported outcomes (PROs) improves prediction of interstitial cystitis (IC)/bladder pain syndrome, according to a study published online April 24 in Urology.
Biomarkers + patient-reported outcomes up prediction of interstitial cystitis
